Brenda S. Furlow's most recent trade in Bio-Techne Corp was a trade of 6,166 Stock Options (Right to Buy) done . Disclosure was reported to the exchange on Aug. 15, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Bio-Techne | Brenda S. Furlow | SVP - General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2022 | 6,166 | 6,166 | - | - | Stock Options (Right to Buy) | |
| Bio-Techne | Brenda S. Furlow | SVP - General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2022 | 1,984 | 1,984 | - | - | Restricted Stock Units | |
| Bio-Techne | Brenda S. Furlow | SVP - General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 177.32 per share. | 08 Aug 2022 | 563 | 6,523 (0%) | 0% | 177.3 | 99,831 | Common Stock |
| Bio-Techne | Brenda S. Furlow | SVP - General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Aug 2022 | 563 | 16,562 | - | - | Stock Options (Right to Buy) | |
| Bio-Techne | Brenda S. Furlow | SVP - General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Aug 2022 | 1,969 | 0 | - | - | Restricted Stock Units | |
| Bio-Techne | Brenda S. Furlow | SVP - General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Aug 2022 | 1,969 | 6,929 (0%) | 0% | 0 | Common Stock | |
| Bio-Techne | Brenda S. Furlow | SVP - General Counsel | Gift of securities by or to the insider at price $ 0.00 per share. | 07 Aug 2022 | 1,330 | 6,290 (0%) | 0% | 0 | Common Stock | |
| Bio-Techne | Brenda S. Furlow | SVP - General Counsel | Gift of securities by or to the insider at price $ 0.00 per share. | 07 Aug 2022 | 1,330 | 1,330 (0%) | 0% | 0 | Common Stock | |
| Bio-Techne | Brenda S. Furlow | SVP - General Counsel | Gift of securities by or to the insider at price $ 0.00 per share. | 07 Aug 2022 | 1,330 | 4,960 (0%) | 0% | 0 | Common Stock | |
| Bio-Techne | Brenda S. Furlow | SVP - General Counsel | Gift of securities by or to the insider at price $ 0.00 per share. | 07 Aug 2022 | 1,330 | 1,330 (0%) | 0% | 0 | Common Stock | |
| Bio-Techne | Brenda S. Furlow | SVP - General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 382.97 per share. | 07 Aug 2022 | 969 | 5,960 (0%) | 0% | 383.0 | 371,098 | Common Stock |
| Bio-Techne | Brenda S. Furlow | SVP - General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Sep 2021 | 6,871 | 9,503 | - | - | Stock Options (Right to Buy) | |
| Bio-Techne | Brenda S. Furlow | SVP - General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 125.05 per share. | 02 Sep 2021 | 6,871 | 14,491 (0%) | 0% | 125.1 | 859,219 | Common Stock |
| Bio-Techne | Brenda S. Furlow | SVP - General Counsel | Sale of securities on an exchange or to another person at price $ 509.67 per share. | 02 Sep 2021 | 5,295 | 9,196 (0%) | 0% | 509.7 | 2,698,711 | Common Stock |
| Bio-Techne | Brenda S. Furlow | SVP - General Counsel | Sale of securities on an exchange or to another person at price $ 510.82 per share. | 02 Sep 2021 | 1,576 | 7,620 (0%) | 0% | 510.8 | 805,054 | Common Stock |
| Bio-Techne | Brenda S. Furlow | SVP - General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 125.05 per share. | 31 Aug 2021 | 5,000 | 12,620 (0%) | 0% | 125.1 | 625,250 | Common Stock |
| Bio-Techne | Brenda S. Furlow | SVP - General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Aug 2021 | 5,000 | 16,374 | - | - | Stock Options (Right to Buy) | |
| Bio-Techne | Brenda S. Furlow | SVP - General Counsel | Sale of securities on an exchange or to another person at price $ 506.12 per share. | 31 Aug 2021 | 3,108 | 7,620 (0%) | 0% | 506.1 | 1,573,011 | Common Stock |
| Bio-Techne | Brenda S. Furlow | SVP - General Counsel | Sale of securities on an exchange or to another person at price $ 505.26 per share. | 31 Aug 2021 | 1,569 | 10,728 (0%) | 0% | 505.3 | 792,755 | Common Stock |
| Bio-Techne | Brenda S. Furlow | SVP - General Counsel | Sale of securities on an exchange or to another person at price $ 503.24 per share. | 31 Aug 2021 | 323 | 12,297 (0%) | 0% | 503.2 | 162,546 | Common Stock |
| Bio-Techne | Brenda S. Furlow | SVP - General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Aug 2021 | 3,538 | 0 | - | - | Stock Options (Right to Buy) | |
| Bio-Techne | Brenda S. Furlow | SVP - General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 106.59 per share. | 19 Aug 2021 | 3,538 | 10,359 (0%) | 0% | 106.6 | 377,115 | Common Stock |
| Bio-Techne | Brenda S. Furlow | SVP - General Counsel | Sale of securities on an exchange or to another person at price $ 474.12 per share. | 19 Aug 2021 | 1,838 | 8,220 (0%) | 0% | 474.1 | 871,427 | Common Stock |
| Bio-Techne | Brenda S. Furlow | SVP - General Counsel | Sale of securities on an exchange or to another person at price $ 473.08 per share. | 19 Aug 2021 | 1,100 | 10,058 (0%) | 0% | 473.1 | 520,391 | Common Stock |
| Bio-Techne | Brenda S. Furlow | SVP - General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Aug 2021 | 799 | 8,704 | - | - | Stock Options (Right to Buy) | |
| Bio-Techne | Brenda S. Furlow | SVP - General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 125.05 per share. | 19 Aug 2021 | 799 | 11,158 (0%) | 0% | 125.1 | 99,915 | Common Stock |
| Bio-Techne | Brenda S. Furlow | SVP - General Counsel | Sale of securities on an exchange or to another person at price $ 475.05 per share. | 19 Aug 2021 | 600 | 7,620 (0%) | 0% | 475.1 | 285,032 | Common Stock |
| Bio-Techne | Brenda S. Furlow | SVP - General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Aug 2021 | 6,080 | 6,080 | - | - | Stock Options (Right to Buy) | |
| Bio-Techne | Brenda S. Furlow | SVP - General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Aug 2021 | 4,560 | 4,560 | - | - | Stock Options (Right to Buy) | |
| Bio-Techne | Brenda S. Furlow | SVP - General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Aug 2021 | 1,374 | 7,498 (0%) | 0% | 0 | Common Stock | |
| Bio-Techne | Brenda S. Furlow | SVP - General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Aug 2021 | 1,374 | 0 | - | - | Restricted Stock Units | |
| Bio-Techne | Brenda S. Furlow | SVP - General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Aug 2021 | 1,167 | 1,167 | - | - | Restricted Stock Units | |
| Bio-Techne | Brenda S. Furlow | SVP - General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 481.82 per share. | 06 Aug 2021 | 677 | 6,821 (0%) | 0% | 481.8 | 326,192 | Common Stock |
| Bio-Techne | Brenda S. Furlow | SVP - General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 10,997 | 10,997 | - | - | Stock Options (Right to Buy) | |
| Bio-Techne | Brenda S. Furlow | SVP - General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 106.59 per share. | 12 Feb 2021 | 10,000 | 16,124 (0%) | 0% | 106.6 | 1,065,900 | Common Stock |
| Bio-Techne | Brenda S. Furlow | SVP - General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2021 | 10,000 | 3,538 | - | - | Stock Options (Right to Buy) | |
| Bio-Techne | Brenda S. Furlow | SVP - General Counsel | Sale of securities on an exchange or to another person at price $ 398.40 per share. | 12 Feb 2021 | 6,674 | 9,450 (0%) | 0% | 398.4 | 2,658,891 | Common Stock |
| Bio-Techne | Brenda S. Furlow | SVP - General Counsel | Sale of securities on an exchange or to another person at price $ 399.12 per share. | 12 Feb 2021 | 3,326 | 6,124 (0%) | 0% | 399.1 | 1,327,461 | Common Stock |
| Bio-Techne | Brenda S. Furlow | SVP - General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 106.59 per share. | 30 Nov 2020 | 10,857 | 16,043 (0%) | 0% | 106.6 | 1,157,248 | Common Stock |
| Bio-Techne | Brenda S. Furlow | SVP - General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Nov 2020 | 10,857 | 0 | - | - | Stock Option (Right to Buy) | |
| Bio-Techne | Brenda S. Furlow | SVP - General Counsel | Sale of securities on an exchange or to another person at price $ 302.15 per share. | 30 Nov 2020 | 6,783 | 6,831 (0%) | 0% | 302.1 | 2,049,476 | Common Stock |
| Bio-Techne | Brenda S. Furlow | SVP - General Counsel | Sale of securities on an exchange or to another person at price $ 301.32 per share. | 30 Nov 2020 | 3,367 | 13,614 (0%) | 0% | 301.3 | 1,014,558 | Common Stock |
| Bio-Techne | Brenda S. Furlow | SVP - General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 106.59 per share. | 30 Nov 2020 | 938 | 16,981 (0%) | 0% | 106.6 | 99,981 | Common Stock |
| Bio-Techne | Brenda S. Furlow | SVP - General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Nov 2020 | 938 | 13,538 | - | - | Stock Option (Right to Buy) | |
| Bio-Techne | Brenda S. Furlow | SVP - General Counsel | Sale of securities on an exchange or to another person at price $ 302.82 per share. | 30 Nov 2020 | 707 | 6,124 (0%) | 0% | 302.8 | 214,093 | Common Stock |